🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 23 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/05/2008 | 13,66 | 14,04 | 13,66 | 13,74 | +0,55% | 2,74% | 69.410 |
| 13/05/2008 | 13,66 | 13,77 | 13,33 | 13,66 | +1,11% | 3,29% | 626.639 |
| 12/05/2008 | 12,80 | 13,59 | 12,76 | 13,51 | +6,49% | 6,43% | 118.969 |
| 09/05/2008 | 12,61 | 12,99 | 12,39 | 12,69 | +0,00% | 4,75% | 440.050 |
| 08/05/2008 | 12,88 | 13,10 | 12,54 | 12,69 | -0,88% | 4,36% | 276.277 |
| 07/05/2008 | 13,74 | 13,74 | 12,80 | 12,80 | -6,56% | 6,81% | 151.457 |
| 06/05/2008 | 13,89 | 14,22 | 13,44 | 13,70 | -2,14% | 5,66% | 116.458 |
| 05/05/2008 | 14,56 | 14,56 | 13,81 | 14,00 | -5,08% | 5,14% | 136.282 |
| 02/05/2008 | 15,91 | 15,91 | 14,49 | 14,75 | -6,64% | 8,94% | 146.300 |
| 01/05/2008 | 15,20 | 15,87 | 14,90 | 15,80 | +4,20% | 6,40% | 52.578 |
| 30/04/2008 | 15,61 | 15,68 | 14,90 | 15,16 | -2,41% | 5,04% | 81.513 |
| 29/04/2008 | 15,87 | 15,87 | 15,23 | 15,53 | -2,12% | 4,01% | 41.625 |
| 28/04/2008 | 16,81 | 16,92 | 15,50 | 15,87 | -6,20% | 8,46% | 81.459 |
| 25/04/2008 | 16,43 | 17,03 | 16,17 | 16,92 | +3,43% | 5,24% | 46.914 |
| 24/04/2008 | 15,46 | 16,47 | 15,46 | 16,36 | +6,07% | 6,54% | 42.586 |
| 23/04/2008 | 15,12 | 15,61 | 14,90 | 15,42 | +2,23% | 4,70% | 34.625 |
| 22/04/2008 | 15,05 | 15,42 | 14,86 | 15,08 | -1,47% | 3,73% | 74.620 |
| 21/04/2008 | 15,12 | 15,65 | 14,78 | 15,31 | +0,00% | 5,69% | 34.304 |
| 18/04/2008 | 15,31 | 15,72 | 15,01 | 15,31 | +2,25% | 4,65% | 100.348 |
| 17/04/2008 | 15,23 | 15,31 | 14,90 | 14,97 | -1,96% | 2,70% | 45.231 |
| 16/04/2008 | 14,52 | 15,42 | 14,30 | 15,27 | +6,53% | 7,73% | 76.917 |
| 15/04/2008 | 14,75 | 14,78 | 14,15 | 14,34 | -2,30% | 4,31% | 94.630 |
| 14/04/2008 | 14,78 | 15,16 | 14,67 | 14,67 | -1,01% | 3,29% | 513.601 |
| 11/04/2008 | 15,38 | 15,57 | 14,67 | 14,82 | -5,04% | 5,84% | 114.160 |
| 10/04/2008 | 15,01 | 16,17 | 14,93 | 15,61 | +4,25% | 8,23% | 113.519 |
| 09/04/2008 | 15,65 | 15,68 | 14,97 | 14,97 | -4,53% | 4,55% | 207.589 |
| 08/04/2008 | 15,61 | 16,02 | 15,42 | 15,68 | -0,71% | 3,84% | 134.358 |
| 07/04/2008 | 15,72 | 16,21 | 15,46 | 15,80 | +1,69% | 4,76% | 144.911 |
| 04/04/2008 | 15,05 | 15,65 | 14,71 | 15,53 | +3,49% | 6,22% | 121.374 |
| 03/04/2008 | 15,23 | 15,27 | 14,67 | 15,01 | -2,67% | 3,93% | 127.492 |